The Most Recent FDA Alerts on Medications, Recalls And Overall Health Concerns and Warnings.
The Following information is broken down by the weeks with the most recent showing first. This is updated when new information is made available. Also, make sure you read up on the Drug Versus Generic information
here
February 04, 2008
Helping Patients Avoid Counterfeit Drugs over the Internet FDA has previously warned about the risks of buying drugs and other medical products over the Internet. Products bought on the Internet could be fake, sub-potent, or not approved by the FDA. They could also be counterfeit.
FDA recently discovered two different web sitesselling a counterfeit version of the weight-loss drug Xenical. In one case, it actually contained another drug, and other samples contained just starch and talc. And that is just one example of the risks people take if they buy drugs over the internet.
An article in a recent issue of "Family Practice Management" gives several tips that practitioners can give to patients to help avoid counterfeit products. One is to advise patients to use only U.S. sites that are licensed by a State board of pharmacy. Some of these sites display the VIPPS seal, which stands for Verified Internet Pharmacy Practice Site. The National Association of Boards of Pharmacy gives the seal to Internet pharmacies that meet State licensure and other criteria.
The article lists some of the drugs that are most susceptible tocounterfeiting and points outs that counterfeiters tend to favor expensive drugs that are sold in large volume, e.g., anti-cholesterol medications. The article notes that so-called "embarrassment drugs" are widely counterfeited i.e., drugs for conditions that patients may be reluctant to discuss with their doctors. This would include drug such as Viagra, Cialis and Propecia.
FDA Takes Actionto Stop the Marketing of Unapproved Injectable Drugs ContainingColchicineThe U.S. Food and Drug Administration today announced itsintention to take enforcement action against companies marketing unapproved injectable colchicine, a drug used to treat gout. Colchicine is a highly toxic drug that can easily beadministered in excessive doses, especially when given intravenously. There is a narrow margin between an effective dose of the drug and a toxic dose that can result in serious health risks, including death. The FDA is aware of 50 reports of adverse events associated with the use of intravenous colchicine, including 23 deaths. Potentially fatal effects include lowblood cell counts, cardiac events, and organ failure. Individuals and companies must stop making these products within 30 days and stop shipping the product within 180 days or face regulatory action which could include seizure, injunction or other legal action deemed appropriate by the agency. After these dates, all injectable colchicine drug products must have FDA approval to be manufactured or shipped interstate.
FDAInvestigation Leads to Several Indictments for Importing Contaminated Ingredients Used in Pet Food Contaminated pet food causedpet illnesses and deaths last yearFebruary 6, 2008
The U.S. Food and Drug Administration's (FDA) Office of CriminalInvestigations announced that two Chinese nationals and the businesses they operate, along with a U.S. company and its president and chief executive officer, were indicted by a federal grand jury today in separate but related cases. The indictments are for their roles in a scheme to import products purported to be wheat gluten into the United States that were contaminated with melamine. These products were used to make pet food.
The indictments allege that more than 800 tons of purported wheatgluten, totaling nearly $850,000, was imported into the United States between Nov. 6, 2006, and Feb. 21, 2007. According to the indictments, SSC falsely declared to the Chinese government that those shipments were not subject to mandatory inspection by the Chinese government prior to export.Melamine can be used to create products such as plastics,cleaning products, glues, inks, and fertilizers. Under certainconditions, melamine mixed with wheat gluten can make the productappear to have a higher protein level than is actually present.Melamine has no approved use as an ingredient in human or animal food in the United States. Wheat gluten is a natural protein derived from wheat or wheat flour, which is extracted to yield a powder with high protein content. Pet food manufacturers often use wheat gluten as a thickener or binding agent in the manufacture of certain types of pet food. Generic FosamaxApprovedThe U.S. Food and Drug Administration today approved the first generic versions of Fosamax (alendronate sodium tablets), used to treat osteoporosis, a conditionthat causes thinning and weakening of a person's bones.
"The FDA works to assure the safety and efficacy of generic drugsthrough a rigorous scientific and regulatory process," said Gary J. Buehler, R.Ph, director of the FDA's Office of Generic Drugs. "These approvals will provide generic options for patients who take Fosamax for their osteoporosis." Fosamax is among the top 100 most frequently dispensed drugs in the United States, according to the trade magazine Drug Topics.
Generic drug manufacturers must demonstrate that a generic drug has the same active ingredient, dosage form, strength, route of administration, quality and performance characteristics, among other things, as the approved brand-name drug.
FDA NotifiesPublic of Adverse Reactions Linked to Botox UseThe U.S. Food and Drug Administration today notified thepublic that Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) have been linked in some cases to adverse reactions, including respiratory failure and death, following treatment of a variety of conditions using a wide range of doses. In an early communication based on the FDA's ongoing safetyreview, the agency said the reactions may be related to overdosing. There is no evidence that these reactions are related to any defect in the products. The adverse effects were found in FDA-approved and nonapproved usages. The most severe adverse effects were found in children treated for spasticity in their limbs associated with cerebral palsy. Treatment of spasticity is not an FDA-approved use of botulism toxins in children or adults. The adverse reactions appear to be related to the spread of the toxin to areas distant from the site of injection, and mimic symptoms of botulism, which may include difficulty swallowing, weakness and breathing problems.
The FDA is not advisinghealth care professionals to discontinue prescribing these products.
FDA Alerts January28, 2008OngoingReview of Cholesterol Drug Vytorin
Merck/Schering Plough Pharmaceuticals issued a press release on January14, 2008, reporting that there was no significant difference foundbetween Vytorin and simvastatin alone in the amount of atheroscleroticplaque in the inner walls of the carotid (neck) arteries, despitegreater lowering of bad cholesterol (LDL).
Until FDA reviews the study data, patients are advised to talk with their health care providers if they have questions about the study or the cholesterol-lowering drug. FDA's Early Communication reinforces its commitment to inform the public about its ongoing drug reviews.
VitalFacts About HIV Home Test KitsIt is important that consumers know there is only one productcurrently approved by FDA and legally sold in the United States as a "home" testing system for HIV. This product is a kit marketed as either "The Home Access HIV-1 Test System" or "The Home Access Express HIV-1 Test System." The kit is a home collection-test system that requires users to collect a blood specimen, and then mail it to a laboratory for professional testing. No test kits allowconsumers to interpret the results at home. class="headBasicCenter">WarningAbout Contaminated Pre-Filled SyringesFDA has announced a nationwide recall of all lots of heparin and salinepre-filled flush syringes manufactured by AM2 PAT, Inc., of Angier,N.C. Two lots have been found to be contaminated with Serratiamarcescens, a bacterium that can cause serious injury ordeath.
The Centers for Disease Control and Prevention has confirmed growth of Serratiamarcescens from unopened heparin syringes.
- Consumers and health care facilities with any of therecalled,pre-filled Heparin Lock or Normal Saline IV Flush syringes should stopusing the product immediately.
- Healthcare facilities should immediately quarantine the products in theirinventory and return them to their distributor.
- Individualconsumers should return them to the location from which they werereceived, such as a pharmacy or hospital.
- Consumers also should let their health care providers knowthat they have been exposed to syringes recalled by FDA.
- Consumerswith questions may contact Sierra Pre-Filled at 919-552-9689, Mondaythrough Friday, 10 a.m. to 5 p.m. EST.
- Report anyadverse reactions experienced with the use of the products, and/orquality problems to FDA's MedWatch Program by phone at 800-FDA-1088, byfax at 800-FDA-0178, by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane,Rockville, M.D. 20852-9787
January21, 2008
PossibleBotulism Risk: New Era Expands RecallNew Era Canning Company, New Era, Mich., is expanding its earlierproduct recall of certain canned beans to include allcanned green beans and garbanzo beans distributed by the companynationwide over the last five years becauseof potential Clostridium botulinum (C. botulinum).
New Era took this voluntary action in the interest of publichealthin accordance with FDA's recall request. The company is takingimmediate action to retrieve all inventories of the products throughoutthe distribution chain, including consumers' homes, nursing homes,schools, warehouses, restaurants, retail stores, health carefacilities, and other facilities. To date, noillnesses have been reported to FDA. But consumers should not consumethese products because of the potential serious health risk. C.botulinum can cause botulism, a serious and sometimeslife-threatening condition. Updateto Label on Birth Control PatchOn January 18, 2008, FDA approved additional changes to the Ortho EvraContraceptive Transdermal (Skin) Patch label to include the results ofa new epidemiology study. The study found that users of the birthcontrol patch were at higher risk of developing serious blood clotsthan women using birth control pills.
Serious blood clots, also known as venous thromboembolism(VTE), canlead to pulmonary embolism (a blockage in an artery in the lung). Thelabel changes are based on a study conducted by the BostonCollaborative Drug Surveillance Program (BCDSP) on behalf of Johnsonand Johnson. The patch was studied in women aged 15-44. These recentfindings support an earlier study that also said women in this groupwere at higher risk for VTE. FDA believes that Ortho Evra is a safe and effective method ofcontraception when used according to the labeling, which recommendsthat women with concerns or risk factors for serious blood clots talkwith their health care provider about using Ortho Evra versus other contraceptive options. FDA notified healthcare professionals and patients about important safety information concerning Edetate Disodium. There have been cases where children and adults have died when they were mistakenly given Edetate Disodium instead of Edetate Calcium Disodium (Calcium Disodium Versenate) or when Edetate Disodium was used for "chelation therapies" and other uses that are not approved by the FDA. Edetate Disodium was approved as an emergency treatment for certain patients with hypercalcemia (very high levels of calcium in the blood) or certain patients with heart rhythm problems as a result of very high amounts ofdigitalis in the blood. Edetate Calcium Disodium was approved to reduce dangerously high blood lead levels (severe lead poisoning).
The two drugs have very similar names and are commonly referred to only as EDTA. As a result, the two products are easily mistaken for each other when prescribing, dispensing, and administering them. Edetate Disodium and Edetate Calcium Disodium works by binding with heavy metals or minerals in the body allowing them to be passed out of the body through the urine. Read the FDA Public Health Advisory for recommended and important safety considerations for healthcare professionals until the FDA's ongoing evaluation of the risks and benefits of Edetate Disodium is complete.
January14, 2008
NewGenetic Test for Breast Cancer PatientsThe U.S. Food and Drug Administration has approved a test that helps in assessing the risk of tumor recurrence and long-term survival for patients with relatively high-risk breast cancer. The TOP2AFISH pharmDx is the first approved device to test for the TOP2A(topoisomerase 2 alpha) gene in cancer patients.The TOP2A gene plays a role in DNA replication. The TOP2AFISH pharmDx test uses fluorescently labeled DNA probes to detect orconfirm gene or chromosome abnormalities, a technology known asfluorescent in situ hybridization (FISH). The recurrence of cancer depends partly on certain genes whoseactivity may be altered by changes in the number of gene copies in thetumor. Changes in the TOP2A gene in breast cancer cells mean there isan increased likelihood that the tumor will recur or that long-termsurvival will be decreased. The test is suitable for breast cancer patients who arepremenopausalor for whom tumor characteristics, such as tumor size or lymph nodeinvolvement, suggest a higher likelihood of tumor recurrence ordecreased survival.

|